Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines are set out in the Schedule hereto:

Schedule

*Product:*	Prucalopride (Medsurge)
Active Ingredient:	Prucalopride succinate 1.321mg equivalent to prucalopride 1mg
Dosage Form:	Film coated tablet
New Zealand Sponsor:	Medsurge Pharma Limited
Manufacturer:	Chanelle Medical Unlimited Company, Loughrea, Ireland

*Product:*	Prucalopride (Medicianz)
Active Ingredient:	Prucalopride succinate 1.321mg equivalent to prucalopride 1mg
Dosage Form:	Film coated tablet
New Zealand Sponsor:	Medsurge Pharma Limited
Manufacturer:	Chanelle Medical Unlimited Company, Loughrea, Ireland

*Product:*	Prucalopride (Medsurge)
Active Ingredient:	Prucalopride succinate 2.642mg equivalent to prucalopride 2mg
Dosage Form:	Film coated tablet
New Zealand Sponsor:	Medsurge Pharma Limited
Manufacturer:	Chanelle Medical Unlimited Company, Loughrea, Ireland

*Product:*	Prucalopride (Medicianz)
Active Ingredient:	Prucalopride succinate 2.642mg equivalent to prucalopride 2mg
Dosage Form:	Film coated tablet
New Zealand Sponsor:	Medsurge Pharma Limited
Manufacturer:	Chanelle Medical Unlimited Company, Loughrea, Ireland

*Product:*	Rosprid
Active Ingredient:	Prucalopride succinate 1.321mg equivalent to prucalopride 1mg
Dosage Form:	Film coated tablet
New Zealand Sponsor:	Medsurge Pharma Limited
Manufacturer:	Chanelle Medical Unlimited Company, Loughrea, Ireland

*Product:*	Rosprid
Active Ingredient:	Prucalopride succinate 2.642mg equivalent to prucalopride 2mg
Dosage Form:	Film coated tablet
New Zealand Sponsor:	Medsurge Pharma Limited
Manufacturer:	Chanelle Medical Unlimited Company, Loughrea, Ireland

Dated this 12th day of May 2025.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on t 11 September 2013).

Tags

Notice Number

Schedule